FNY Partners Fund’s Evolent Health EVH Stock Holding History

FNY Partners Fund’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$210K	Buy	14,750 +8,550	+138%	+$122K	0.11%	101
2017 Q4	$76K	Buy	+6,200	New	+$87.4K	0.01%	225
2017 Q2	–	Sell	-1,000	Closed	-$22K	–	737
2017 Q1	$22K	Buy	+1,000	New	+$19.2K	﹤0.01%	920

Other funds holding EVH

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Formula Growth Montreal, Quebec, Canada $284M AUM 54.56% 1-Year Est. Return

FNY Partners Fund's EVH Position: Q1 2018 in Review

FNY Partners Fund increased its Evolent Health (EVH) stake by 138% in Q1 2018, buying an estimated $122K and bringing the position to 14,750 shares worth $210K. The position accounts for 0.11% of the portfolio, ranked #101.

FNY Partners Fund first reported a position in EVH in Q1 2017 and has held it in 3 quarters since. 152 funds tracked by Wall St. Rank hold EVH as of Q1 2018.

FNY Partners Fund held 14,750 shares of Evolent Health worth $210K as of Q1 2018.
FNY Partners Fund bought 8,550 Evolent Health shares in Q1 2018, an estimated $122K.
Evolent Health made up 0.11% of FNY Partners Fund's portfolio in Q1 2018, its #101 holding.
FNY Partners Fund first reported a position in Evolent Health in Q1 2017 and has held it in 3 quarters since.
152 funds tracked by Wall St. Rank held Evolent Health as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.